£20,000 in savings? Here’s how I’d aim to turn that into a £7,614 monthly second income!

Putting money into high-quality FTSE 100 and FTSE 250 shares can help investors unlock a life-changing second income over time.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Rear View Of Woman Holding Man Hand during travel in cappadocia

Image source: Getty Images

Charlie Munger famously said: “The first rule of compounding: Never interrupt it unnecessarily.” This tenet applies whether an investor has already built up a large second income or is still working towards one.

Therefore, it’s always a good idea to have some savings set aside for a rainy day. Back in the day, a rainy day would have made it difficult to work outdoors and earn income (hence the phrase).

Nowadays, it could be anything from a broken boiler to a poorly pet. The last thing an investor wants to do is sell stocks (potentially at a loss) to cover an unforeseen bill. So Cash ISAs definitely have a role to play.

But assuming this base is covered, I’d want the rest of my savings in a Stocks and Shares ISA over the long run. Here’s why.

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.

Stairs and elevators

Put simply, stocks deliver better long-term returns than other asset classes, particularly cash.

This doesn’t mean they’re always a sure bet, mind. Reduced dividends, bear markets and crashes, and a myriad of other events (wars, pandemics, financial panics, etc.) do happen. Often unexpectedly.

That’s why the stock market tends to deliver superior returns over time. Investors want a higher potential rate of return for taking on all this extra risk. Otherwise, why bother putting oneself through the wringer?!

Also, as a general rule, stock markets take the stairs up and the elevator down. In other words, they rise steadily but can drop dramatically.

That’s why it’s important to take a long-term, Foolish approach to investing.

Of course, tuning out all the noise when things are going south isn’t easy. But it is possible to cultivate a patient mindset with enough experience.

Life-changing passive income

Long term, the blue-chip FTSE 100 has returned almost 8% a year on average, while the mid-cap FTSE 250 has delivered around 10.5%. Both figures are with dividends reinvested rather than spent.

If this record continues, a £20k lump sum equally invested across these indexes would turn into an eye-catching £304,406 over the next 30 years (excluding any ISA platform fees).

However, if I decided to invest a further £650 a month – the equivalent of £150 a week – along the way, my total would be transformed into a mighty £1,522,806. So, just over £1.5m!

From this, I could decide to take £91,368 a year in passive income from a 6%-yielding dividend portfolio. That’s the equivalent of a tax-free £7,614 monthly second income.

A world-class company

To achieve this, I’d build a portfolio with quality stocks like AstraZeneca (LSE: AZN).

There are a number of things I like here. For starters, the pharma giant has 12 blockbuster drugs (those generating $1bn in annual sales) as well as a gigantic pipeline of future potential wonder treatments.

Naturally, some won’t come to fruition, meaning clinical trial failures are an unavoidable risk. But I find Astra’s deep pipeline reassuring.

Second, the company remains extremely ambitious. It recently said it’s aiming to grow revenue by about 75% to $80bn by 2030.

This will be through the potential launch of 20 new medicines as well as growth in its existing oncology, biopharmaceuticals, and rare disease portfolio.

Given this possibility and the firm’s excellent recent record of execution, I find the stock’s forward price-to-earnings multiple of 18.7 attractive.

Ben McPoland has positions in AstraZeneca Plc. The Motley Fool UK has recommended AstraZeneca Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Workers at Whiting refinery, US
Investing Articles

Why is everyone selling BP shares?

BP shares have been some of the most sold in the last week. What's going on here? And could this…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

Is this market correction a once-in-a-decade chance to buy ultra-high-yield income stocks?

As share prices fall, dividend yields rise. The FTSE 100 is full of top income stocks and Harvey Jones says…

Read more »

This way, That way, The other way - pointing in different directions
Investing Articles

Down 25% in a month! Are these the 3 best stocks to buy in today’s correction… or the worst?

Harvey Jones examines whether the best stocks to buy today can all be found in the FTSE 100 sector that…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

This FTSE small-cap stock can surge 105%, says one broker

Ben McPoland highlights a FTSE small-cap share that's trading cheaply and offering a dividend for the first time since 2019.

Read more »

A mature adult sitting by a fireplace in a living room at home. She is wearing a yellow cardigan and spectacles.
Investing Articles

£10,000 invested in ultra-high yield Legal & General shares on 5 April last year is now worth…

Investors typically buy Legal & General shares for the dividend income, as they now yield more than 8.5%. But will…

Read more »

Modern apartments on both side of river Irwell passing through Manchester city centre, UK.
Investing Articles

With an empty ISA today, how long would it take to aim for a million?

Is it realistic to aim for a million with an empty ISA? Our writer turns from fantasy to facts to…

Read more »

Burst your bubble thumbtack and balloon background
Investing Articles

What on earth’s going on with the Helium One share price?

The Helium One share price rally has stalled. Our writer reflects on the reasons and asks whether now could be…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Getting started with investing? Here are 3 UK stocks to take a look at

The next time the stock market opens, it will be the new financial year. And Stephen Wright has three UK…

Read more »